This significantly reduced the tumour weight as well as the number of peritoneal metastases in mice treated with sgElovl1 OT-I T cells and anti-PD-1, but not in mice receiving anti-PD-1 or sgElovl1 OT-I T cells alone (Fig. 3a,b). This evidence concerns the gene PDCD1 and neoplasm.